360 Stem Cell & Regenerative Medicine Newsletter - Oct 28, 2014

 weSRCH's Best of the Internet Award

360 Stem Cell & Regenerative Medicine Newsletter - Oct 28, 2014

Featured Video : Huntington’s Disease: Who is HD-CARE?

This is a must-see 4-minute video from HD Care, one of the Huntington’s disease community’s premier patient groups. HD Care supports the research at UC-Irvine to understand and provide effective treatments for this horrific affliction. UC Irvine researchers have reprogrammed skin cells from HD patients to create disease burdened stem cell lines, a very important research tool. Note: HD Care is one of the grassroots patient groups being recognized by the Genetics Policy Institute with a Stem Cell Action Award at the 10th anniversary World Stem Cell Summit Awards Dinner, December 3rd, in San Antonio.
Washington University School of Medicine: Targeting Huntington’s Disease- human skin cells reprogrammed directly into brain cells
According to a media release, “The investigators produced a specific type of brain cell called medium spiny neurons, which are important for controlling movement. They are the primary cells affected in Huntington's disease. The research involved adult human skin cells, rather than more commonly studied mouse cells or even human cells at an earlier stage of development. In regard to potential future therapies, the ability to convert adult human cells presents the possibility of using a patient's own skin cells, which are easily accessible and won't be rejected by the immune system.” The research was published in the journal Neuron.
Advancing the clinical application of cord blood stem cells cbr
California’s Stem Cell Agency Unveils CIRM 2.0 – its Aggressive Plan to Significantly Accelerate Promising Therapies. Invests $24 Million To Create Alpha Clinic Network
CIRM president Dr. C. Randal Mills unveiled the Agency’s plans for CIRM 2.0, detailing an approach that would significantly reduce the amount of time it takes to approve funding for a potential therapy heading into a clinical trial. In addition, CIRM awarded $24 million to set up three new clinical trial centers. “The awards, part of the Agency’s Alpha Stem Cell Clinics program, are to create one-stop centers for clinical trials enabling patients to have safe, fast and easy access to life-saving or life-changing stem cell therapies. The awards of $8 million each go to the City of Hope, UCLA and UCSD.”
cryoport global frozen shipping for life sciences
Harvard Stem Cell Institute (HSCI): Scientists engineer toxin-secreting stem cells to treat brain tumors
HSCI scientists at Massachusetts General Hospital have devised a new way to use stem cells in the fight against brain cancer. A team led by neuroscientist Dr. Khalid Shah, now has a way to genetically engineer stem cells so that they can produce and secrete tumor-killing toxins. Shah’s team shows how the toxin-secreting stem cells can be used to eradicate cancer cells remaining in mouse brains after their main tumor has been removed. The research was reported in the AlphaMed Press journal Stem Cells.
Targeted Technology
San Antonio Health Connect: World Stem Cell Summit announces exclusive tour of three of San Antonio’s science facilities for Summit attendees
World Stem Cell Summit (WSCS14) announced an exclusive opportunity – only available to Summit participants – to tour three of San Antonio’s science powerhouses on December 2nd, one day before the 10th annual World Stem Cell Summit #WSCS14, December 3-5 at the Marriott Rivercenter in San Antonio, Texas. On Tuesday, December 2nd, the day before the Summit begins, a limited number of Summit attendees will have the opportunity to tour three world-class facilities: BioBridge Global, the Southwest National Primate Research Center (SNPRC) at the Texas Biomedical Research Institute and the Southwest Research Institute (SwRI). Advanced registration is required and space is limited for this opportunity.
get your research to space Casis
Breaking News: Free Stem Cell Public Education Day at World Stem Cell Summit in San Antonio, Dec.2.
Milwaukee Journal Sentinel: Cellular Dynamics International (CDI) awarded National Eye Institute contract
This is a well-written profile about the activities of CDI, one of the leading RegMed companies. “In a key step advancing the use of reprogrammed stem cells, Madison-based Cellular Dynamics International Inc. has received a $1.2 million contract from the National Eye Institute to engineer cells for the potential treatment of macular degeneration, one of the leading causes of blindness. Under the contract, the Eye Institute, part of the National Institutes of Health, will send the Madison company blood and tissue from 10 patients with age-related macular degeneration. Cellular Dynamics will convert the blood or tissue into stem cells, then program them to become new retinal cells of the type damaged in macular degeneration. Ultimately, the goal — still several years away — is to transplant the reprogrammed cells back into the original patients to treat the condition.” Note: CDI is a presenting company at the first RegMed Capital Conference as part of WSCS14 in San Antonio.
New report: Cell line development market worth $3.96 billion by 2019
According to the new market research report, “The Cell Line Development Market by Product (Equipment, Media and Reagents), by Source, by type, by Application ( Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research, Drug Discovery) - Analysis & Global Forecast to 2019”, published by MarketsandMarkets, analyzes and studies the major market drivers, threats, opportunities, and challenges. The report studies the global Cell Line Development Market for the forecast period of 2014 to 2019.This market is expected to reach $3.96 Billion by 2019 from $2.2 Billion in 2014, and is poised to grow at a CAGR of 12.5% from 2014 to 2019.
PostBulletin.com: Mayo Clinic & Rochester, MN wooing Cardio3 Biosciences
Mayo Clinic and Cardio3 have collaborated for years on the cardiopoiesis technology the company uses to repair patients' hearts by re-programming their own stem cells to regenerate cardiac tissue. This article explains how the Mayo Clinic and City of Rochester aim to recruit Cardio3 into an expanded Mayo Clinic Business Accelerator and Biobusiness Center- luring 350 new jobs to the community.
“Personhood” measures on November ballot in North Dakota and Colorado
Editorial comment: A consequence of a jurisdiction or nation providing fundamental constitutional or human rights to human cells at conception would be the end of IVF and embryonic stem cell research. It would create widespread confusion and legal chaos. Bottom line: the principle of “personhood” at conception is unscientific, unenforceable, unconstitutional, untenable and ultimately damaging to a civil society.

360 Newsletter Editor

Bernard Siegel
Executive Director
Genetics Policy Institute

Stem Cells and the Transformative Power of Hope-a TEDx talk by Bernard Siegel, Editor of 360 Newsletter
Domain: Medical
Category: Biology

Recent Newsletters

12 March, 2019
10 October, 2018
15 February, 2018